Additionally, we examined ISG20 expressions across publicly available RNA sequencing data of 1247 breast cancer patients and found that ISG20 levels are significantly higher in breast tumor tissues compared to normal mammary tissues (p ≤ 0.0001) (Fig. 6d). Here, ISG20 is linked to breast carcinoma.